BackgroundThe rising burden of antimicrobial resistance (AMR) necessitates new bioactive molecules that are both sustainable and therapeutically relevant. Endophytic actinomycetes, particularly Streptomyces, represent a valuable but underexplored source of secondary metabolites with pharmaceutical potential.MethodsAn endophytic strain, Streptomyces sp. VITGV100, was isolated from tomato stems and…
This paper describes the development of a platform technology for a new class of antimicrobial biologicals called AbTids to target drug resistant bacteria using pathogen specific camelid antibodies and antimicrobial peptide conjugates.
